Company: IMG
Filing Date: 2025-07-21
Form Type: 10-K
Source: 0001641172-25-020300
Chunk: 189

Company: CIMG Inc.
Filing Date: 2025-07-21
Form: 10-K
Item: Item 1
Chunk 189
---
, agreements with third parties, and make sales in China. Companies with operations in China have been accused and found
guilty of sales practices that involve unlawful activity, including violations of the FCPA. We believe to date we have complied in all
material respects with the provisions of the FCPA. However, our existing safeguards and any future improvements may prove to be less
than effective, and the employees, consultants and/or distributors of our Company may engage in conduct for which we might be held responsible.
Violations of the FCPA may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could negatively
affect our business, operating results and financial condition. In addition, the government may seek to hold our Company liable for successor
liability FCPA violations committed by companies in which we invest or that we acquire.

39

Risks
Related to Ownership of our Common Stock

The
market price of our stock may be volatile, and you could lose all or part of your investment.

The
trading price of our Common Stock is likely to be highly volatile and subject to wide fluctuations in response to various factors, some
of which we cannot control. In addition to the factors discussed in this “Risk Factors” section and elsewhere in this Report,
these factors include but are not limited to:

    ●
    the
    success of, or developments in, competitive products, services or technologies;
  
    ●
    regulatory
    actions with respect to our products and our competitors;
  
    ●
    the
    level of success of our marketing strategy;
  
    ●
    announcements
    by us or our competitors of significant acquisitions, strategic collaborations, joint ventures or capital commitments;
  
    ●
    regulatory
    or legal developments in the United States and other countries;
  
    ●
    recruitment
    or departure of key personnel;
  
    ●
    expenses
    related to any of our development programs and our business in general;
  
    ●
    actual
    or anticipated changes in financial estimates, development timelines or recommendations by securities analysts;
  
    ●
    failure
    to meet or exceed financial estimates and projections of the investment community or that we provide to the public;
  
    ●
    variations
    in our financial results or those of companies that are perceived to be similar to us;
  
    ●
    fluctuations
    in the valuation of companies perceived by investors to be comparable to us;
  
    ●
    share